JHU-083
JHU-083 is an experimental drug which acts as a glutaminase inhibitor.
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
JHU-083 is an experimental drug which acts as a glutaminase inhibitor. It is a prodrug which is cleaved in vivo to the active form 6-diazo-5-oxo- L -norleucine. It has been researched for the treatment of various neurological conditions such as depression, Alzheimer's disease, and cerebral malaria, as well as multiple sclerosis, atherosclerosis, hepatitis, and some forms of cancer in which it was found to target senescent cells.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1374092633 under CC BY-SA 4.0; modifications have been made.